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ABSTRACT
Silver nanoparticles (AgNPs), embedded into a specific polysaccharide (EPS), 
were biogenerated by Klebsiella oxytoca DSM 29614 under aerobic (AgNPs-EPSaer) 
and anaerobic conditions (AgNPs-EPSanaer). Both AgNPs-EPS matrices were tested 
by MTT assay for cytotoxic activity against human breast (SKBR3 and 8701-BC) and 
colon (HT-29, HCT 116 and Caco-2) cancer cell lines, revealing AgNPs-EPSaer as the 
most active, in terms of IC50, with a more pronounced efficacy against breast cancer 
cell lines. Therefore, colony forming capability, morphological changes, generation 
of reactive oxygen species (ROS), induction of apoptosis and autophagy, inhibition 
of migratory and invasive capabilities and proteomic changes were investigated 
using SKBR3 breast cancer cells with the aim to elucidate AgNPs-EPSaer mode of 
action. In particular, AgNPs-EPSaer induced a significant decrease of cell motility and 
MMP-2 and MMP-9 activity and a significant increase of ROS generation, which, in 
turn, supported cell death mainly through autophagy and in a minor extend through 
apoptosis. Consistently, TEM micrographs and the determination of total silver in 
subcellular fractions indicated that the Ag+ accumulated preferentially in mitochondria 
and in smaller concentrations in nucleus, where interact with DNA. Interestingly, 
these evidences were confirmed by a differential proteomic analysis that highlighted 
important pathways involved in AgNPs-EPSaer toxicity, including endoplasmic reticulum 
stress, oxidative stress and mitochondrial impairment triggering cell death trough 
apoptosis and/or autophagy activation.
INTRODUCTION
Cancer is a multifaceted disease, extremely variable 
in its presentation, development and outcome. It is well 
established that cancer is a multifactorial disease caused 
by a complex mixture of genetic and environmental 
factors. However the knowledge of the genetic, molecular, 
and cellular basis of cancer can provide new targets and 
strategies for therapy. Many anticancer drugs are unable 
to reach their target site in sufficient concentrations and 
efficiently exert the pharmacological effect without 
causing irreversible unwanted injury to healthy tissues 
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and cells [1–3]. Nanotechnology offers a wealth of 
tools to treat cancer by passing biological barriers to 
deliver therapeutic agents directly [4]. The unique 
physicochemical characteristics of metal NPs, such as 
high surface-to-volume ratio, broad optical properties, 
ease of synthesis and surface functionalization offer new 
opportunities for cancer therapeutics. The production of 
silver nanoparticles (AgNPs) has become the object of 
intense research and several methods have been developed 
to synthesize noble metal NPs, including physical and 
chemical ones [5–7]. 
The biological synthesis of AgNPs have received 
increasing attention due to the growing need of 
developing eco-friendly (i. e. “green”) technologies 
in material synthesis [6,8–12]. Thus, different 
microorganisms, either bacteria or fungi, have been 
used as potential cell-factories for both intra and extra 
cellular production of AgNPs [9, 13]. The mechanism of 
biological formation of metal-NPs is mainly due to the 
capability of biopolimers and, in particular, microbial 
exopolysaccharides (EPS) to act as metal reducers and/
or stabilizers [14–16]. The Klebsiella oxytoca DSM 
29614 EPS is composed of a branched heptasaccharide 
repeating unit (1 galactose, 4 rhamnoses, 2 glucuronic 
acids), with metal binding properties during the 
fermentative biosynthetic process [17, 18]. K. oxytoca 
strains are ubiquitous bacteria mainly studied as 
opportunistic pathogens which are responsible for 
nosocomial infections [19]. However, many K. oxytoca 
strains are also known to produce exopolysaccharides 
of environmental and pharmaceutical interest [17, 20]. 
Furthermore, the production of other metal nanoparticles 
embedded in this EPS has already been reported [21–25].
In this study, we tested the anticancer effect of 
biogenerated AgNPs-EPS on different cancer cell lines, 
and then investigated its molecular mechanism of action 
in the SKBR3 breast cancer cell line. In particular, 
we found that AgNPs-EPSaer caused: i) a significant 
decrease of cell viability and motility, ii) an impairment 
of MMP-2 and MMP-9 activity, and iii) a promotion 
of ROS generation, which, in turn, induced cell death 
through apoptosis and autophagy. These evidences 
were confirmed by a differential proteomic analysis, 
in which proteomic changes are consistent with the 
activation of important pathways including endoplasmic 
reticulum stress, oxidative stress and mitochondrial 
disfunction triggering cell death trough apoptosis and/
or autophagy activation. Finally, TEM micrographs and 
the determination of total silver in subcellular fractions 
reinforce the idea that Ag+ released from AgNPs-EPSaer 
firstly in mitochondria and then in nuclei determines cell 
damage and death.
To the best of our knowledge, this is the first study 
reporting the mechanism of action of biosynthesized 
AgNPs through an integrated proteomic approach.
RESULTS
Cytotoxic effects of AgNPs-EPS 
The cytotoxic effect of AgNPs biogenerated by 
Klebsiella oxytoca DSM 29614 under aerobic (AgNPs-
EPSaer) and anaerobic conditions (AgNPs-EPSanaer) was 
investigated after 24 h of treatment on two human breast 
cancer cell lines (SKBR3 and 8701-BC) and three human 
colon cancer cell lines (HT-29, HCT 116 and Caco-2) by 
using the MTT assay. The results, expressed as IC50 values, 
calculated from the dose-survival curves, are reported in 
Table 1. The AgNPs-EPSaer is more active than AgNPs-
EPSanaer, with SKBR3 and 8701-BC cell lines being more 
sensitive to AgNPs-EPSaer treatment in comparison to 
HT-29, HCT 116 and Caco-2 colon cancer cell lines. In 
particular, SKBR3 cells proliferation was significantly 
inhibited by AgNPs-EPSaer with an IC50 value of 5 μg/ml, 
while an IC50 value of 8 μg/ml was found for 8701-BC cell 
line. These values were found well within the clinically 
acceptable concentration of 100 μg/ml [26], suggesting a 
potential anticancer effect of both biogenerated AgNPs-
EPS. Since AgNPs-EPSaer contains more total silver than 
AgNPs-EPSanaer [24] and the amount of Ag+ released from 
AgNPs-EPSaer is significantly higher than for AgNPs-
EPSanaer [25], we believe that the biological activity of 
AgNPs-EPS is Ag-dependent. None toxic effect was 
observed for metal-free EPS. 
Since AgNPs-EPSaer had the highest cytotoxic 
activity towards breast cancer SKBR3 cells, the selectivity 
index (SI) was investigated by using a non tumoral 
mammary epithelial cell line (HB2), as previously reported 
[27]. Cytotoxic assays were performed for 24h and 48h, 
and doxorubicin was used as a positive control (Table 
2). The SI were quite similar between AgNPs-EPSaer 
and doxorubicin, a commonly used chemotherapeutic 
drug [28]. Moreover, this investigation revealed high 
selectivity for SKBR3 cells [29], with higher SI value for 
higher treatment time, being SI 3.4 and 5.0 after 24 and 
48 h, respectively. Based on these results, SKBR3 cells 
were further used to study the mechanisms of cytotoxicity 
associated with the AgNPs-EPS treatments.
Colony formation assay
In order to assess SKBR3 cell viability in terms of 
reproductive capacity after treatments with the two kinds 
of AgNPs-EPS, a colony formation assay was performed 
[30]. To this aim, cells were seeded in appropriate dilutions 
and treated with two different concentrations (50 and 5 
µg/ml) for 1 and 24 h, maintained under normal culture 
conditions and analysed two weeks later for the formation 
of colonies. The results (Figure 1) showed that AgNPs-
EPSaer treatment inhibited significantly the colony-forming 
ability of SKBR3 cells in a dose- and time-dependent 
manner and, interestingly, resulted effective already 
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after 1 h-treatment. On the other hand, AgNPs-EPSanaer 
treatment inhibited cell proliferation in a dose- and time-
dependent manner only at the highest dose of 50 µg/ml. 
Thus, according MTT assay results, AgNPs-EPSaer exerts a 
superior biocide activity in comparison to AgNPs-EPSanaer. 
None effect was observed for free-metal EPS.
AgNPs-EPS inhibit motility and MMPs activity 
in SKBR3 cells 
Migration and invasion represent a cancer 
progression hallmark [31], so we tested the effect of 
Ag-NPs-EPS on cell motility by performing a wound-
Figure 1: Cytotoxic effect of AgNPs-EPS in SKBR3 cells evaluated by clonogenic assay. (A) Culture dishes with stained 
colonies of a representative experiment; (B) Statistical results of colony-forming assays presented as percentage of colonies numbers in the 
respect of untreated cells  used as control. Statistical significance was assessed by the Student’s t-test: *p < 0.05 was considered significant; 
***p < 0.001 very highly significant. The data in the graphs are expressed as mean number ± SD of three different experiments.
Table 1: IC50 values at 24 h of Ag-NPs-EPS in selected cancer cell lines
IC50 (μg/ml) ± SD
 AgNPs-EPSanaer AgNPs-EPSaer Metal free-EPS
SKBR3 50 ± 1.5 5 ± 0.5 NA
8701-BC 75 ± 1.3 8.2 ± 0.8 NA
HT29 NA 20 ± 2 NA
HCT116 NA 26 ± 2 NA
CaCo2 NA 34 ± 4 NA
Table 2: IC50 values calculated at 24 and 48 h of AgNPs-EPSaer treatment, in SKBR3 breast cancer 
cell line and in the non tumoral epithelial mammary cell line HB2
HB2 IC50 ± SD SKBR3 IC50 ± SD
Selectivity index SI 
(HB2IC50/SKBR3 IC50)
24 h 48 h 24 h 48 h 24 h 48 h 
AgNPsaer 17 ± 0.5a 9 ± 0.8a 5 ± 0.5a 1.8 ± 0.8a 3.4 5
Doxorubicin 15.8 ± 2,1b 5.3 ± 1b 4.1 ± 0.5b 1.12 ± 0.1b 3.8 4.8
SI was calculated as ratio between AgNPs-EPSaer IC50 values obtained for HB2 and SKBR3. 
aValues expressed as µg/ml; 
bvalues expressed as µM.
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healing assay. Results (Figure 2A) showed an inhibition 
of migratory ability both at 6 and 24 h in AgNPs-EPSaer 
treated cells. AgNPs-EPSanaer treatment did not affect 
significantly the migratory capability of SKBR3 cells. 
Cell migration represent a complex process that involves 
the expression of a number of growth factors, cytokines 
and matrix metalloproteinases (MMPs) [32, 33]. Because 
of the significant effects induced by AgNPs-EPSaer on cell 
migration, we evaluated the effects on MMP-2 and MMP-
9 enzymatic activities and protein expression in SKBR3 
cells using gelatin zymography and western blot. Data 
revealed a significant decrease of enzymatic activities in 
AgNPs-EPSaer treated cells with the maximum effect for 
pro MMP-9 that is almost disappeared. AgNPs-EPSanaer 
(Figure 2B, 2C and 2D) treatment instead did not affect 
significantly the activity levels of MMPs, accordingly to 
the scratch assay results.
Morphological assessment of SKBR-3 cells 
treated with both AgNPs-EPS 
The morphology of SKBR3 cells treated with either 
AgNPs-EPSaer and AgNPs-EPSanaer were significantly 
changed in comparison to the untreated control cells: treated 
cells showed apoptotic-like symptoms such as cell shrinkage 
and detachment from the adjacent cells especially in the case 
of AgNPs-EPSaer treatment. Moreover, irregularity in shape, 
cytoplasmic blebbing, intracellular vacuoles, cellular debris 
and nuclear chromatin condensation were clearly observed 
(Figure 3A). No morphological changes were observed for 
free-metal EPS (data not shown). AO/EB staining technique 
was used to verify whether the AgNPs-EPS-cell death is due 
to apoptotic induction or unspecific necrosis. As expected 
(Figure 3B), the control cells emitted only green fluorescence 
due to the AO staining. On the contrary, the AgNPs-EPS 
treated cells exhibited orange fluorescence (sensitive to pH 
lowering) due to the loss in membrane integrity. In particular, 
in AgNPs-EPSanaer treated cells, only membrane blebbing 
and condensed chromatin were observed, while in AgNPs-
EPSaer treated cells, loss of membrane integrity, condensed 
chromatin and nuclei stained with EB, were observed. 
Effect of AgNPs-EPS treatment on intracellular 
oxygen species
Elevation of intracellular ROS levels is known to 
induce oxidative stress and cell death [34, 35]. Several 
studied reported that AgNP cytotoxicity is primarily 
Figure 2: AgNPs-EPSaer inhibit wound healing and MMP9/MMP2 activity in SKBR3 cells. (A) Inhibitory effect on cell 
migration assessed by wound healing assay and quantified by measuring the scratched area. (B) Zymographic analysis of MMP9 and MMP2 
activity in SKBR3 cells. The gelatinolytic bands correspond to the pro MMP9 and pro MMP2. (C) Densitometric analyses of proMMP2 
and MMP9 secretion. Statistical significance was assessed by the Student’s t-test: *p < 0.001. The data in the graphs are expressed as mean 
of the band-intensity ± SD. (D) Western blot validation of MMP9 and MMP2 protein expression in conditioned media.
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the result of oxidative stress [36, 37], which in turn 
induces cell death through several supposed molecular 
mechanisms such as activation of intrinsic pathway of 
apoptosis, autophagy or both [38–41]. We investigated 
the effect of AgNPs-EPS on intracellular levels of ROS 
by dichlorodihydrofluorescein diacetate (DCFH-DA) and 
Dihydroethidium (DHE) assays, two generic indicators 
of cellular ROS levels. As shown in Figure 4, after 24 
h of exposure AgNPs-EPSaer induced a remarkable ROS 
increase in a concentration-dependent manner. Compared 
to the control cells, a maximum of 2.25 and 1.75 fold 
increases in ROS generation was observed with 10 µg/ml 
concentration of AgNPs-EPSaer treatment, in DCFH-DA 
and DHE assay respectively, suggesting an important role 
of ROS in cell death induction. AgNPs-EPSanaer treatment 
did not affect significantly intracellular levels of ROS in 
comparison to the control cells. 
Detection of Apoptosis and autophagy 
We examined whether AgNPs-EPS-induced cell 
death occurs via apoptosis, autophagy, or both. Flow 
cytometry analysis (Figure 5A) revealed that only the 
11.57% of AgNPs-EPSaer treated cells underwent to 
apoptosis compared to the 5.50% in untreated cells and 
doxorubicin treated cells (27.81%), while no apoptosis was 
recorded for AgNPs-EPSanaer treated cells (5.58%) and for 
free-metal EPS treated cells (6.06%). Accordingly, no DNA 
fragmentation was evident in SKBR3 cells after 24 h of Ag-
NPs-EPS exposure (Figure 5B), suggesting that apoptosis 
was not prominent in AgNPs-EPSaer -induced cell death, at 
least in the first 24 h of treatment. Therefore, three different 
staining specific for lysosomal/vacuolar activity include 
Lysotracker® (a fluorescent acidotropic probe used for 
labeling acidic organelles in live cells such as lysosomes/
vacuoles), MonoDansylCadaverine (MDC) (a weak 
base able to label autophagosomes and autolysosomes) 
and Acridine Orange (AO) (a fluorescent basic dye that 
accumulates in acidic compartments, such as lysosomes and 
vacuole) were used to investigate autophagy. AgNPs-EPSaer 
treated cells (Figure 5C) showed autophagolysosomes 
in the cytoplasm detected by fluorescence microscopy as 
bright punctate dots [42, 43]. Moreover the expression of 
autophagic markers such as AKT, p-AKT, ATG5, ATG7, 
HSP90, P62, LC3I/II protein and beclin I, were analyzed 
by Western blot (Figure 5D). As expected, we observed 
a concomitant down regulation of AKT, p-AKT, p62 
and HSP90 expression and an up-regulation of ATG5, 
ATG7, LC3-II and beclin-1 in AgNPs-EPSaer treated cells, 
indicating a prominent mechanism of autophagic cell death. 
Effect of AgNPs-EPS on SKBR3 proteome 
Differential proteomic analysis (2D-DIGE) was 
performed to detect protein modulations induced by both 
AgNPs-EPS on SKBR-3 cells, after 24 h of treatments 
Figure 3: Morphological changes in SKBR3 cells treated with AgNPs-EPS. (A) Inverted phase-contrast micrographs 
Magnification 200X. (B) Fluorescence microscope micrographs after AO/EB double staining. Magnification 680X. Viable cells (blank 
arrow), membranes blebbing (yellow arrow), loss of membrane integrity, condensed chromatin and nuclei stained with EB (red arrows). 
Each experiment was performed in triplicate (n = 3) and generated similar morphological features.
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in order to unveiling molecular pathways involved in 
AgNPs-EPSaer cytotoxicity. A total of six gels were run 
to achieve a statistically significant measure of the 
differences in protein expression between the analyzed 
groups. Protein spots were quantified, normalized and 
inter-gel matched and only differentially expressed 
proteins with the threshold settings with at least fold 
change ≥ 1.3 and p-value < 0.01, were considered 
regulated (Supplementary Table 1). Figure 6A shows 
a prototype of proteomic map of SKBR3 cells with 
253 labels corresponding to the protein spots showed a 
significant difference. Among the differentially expressed 
spots (Figure 6B), 202, corresponding to 80%, were 
selectively modulated in AgNPs-EPSaer treated cells, 
only two proteins spots were modulated selectively in 
AgNPs-EPSanaer and only two in EPS free metal treated 
cells, confirming the prominent biological activity of 
AgNPs-EPSaer. Overlapping modulations are shown, also. 
The trend of up and down regulated proteins compared 
to untreated cells are shown in Figure 6C. Protein 
identification was performed by MALDI TOF-MS/MS 
analysis. We successfully identified 118 protein spot, 
corresponding to 83 proteins (Supplementary Table 2). 
Several proteins were found in different isoforms and 
then detected in multiple spots. In order to construct 
protein-protein interaction networks regulated by AgNPs-
EPSaer we used STRING database [44]. Figure 7A depict 
the interaction networks of the AgNPs-EPSaer regulated 
Figure 4: Effect of AgNPs-EPS treatment on intracellular ROS generation. ROS were measured using DCFH-DA (A) and 
DHE (B) and quantified through spectrofluorometry. Data were normalized for cell number determined by MTT assay and expressed 
as percentage in respect to the untreated cells used as control. Statistical significance was assessed by the Student’s t-test: *p < 0.05 was 
considered significant, **p < 0.01 highly significant and ***p < 0.001 very highly significant. The data are expressed as mean value ± SD. 
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protein, in which is possible to observe a group of proteins 
biologically connected, with several interactions among 
themselves. Functional enrichments analysis performed 
by using gene ontology terms, allow us to better 
understand the molecular mechanisms underlying the 
cellular responses triggered by AgNPs-EPSaer: Figure 7B 
shows the protein clusters involved in different biological 
processes (protein folding, oxido-reduction processes, 
regulation of cell death, response to stress and in 
particular to reactive oxygen stress), molecular functions 
(essentially binding capability e.g proteins and nucleic 
acid, and oxidoreductase activity) and cellular component 
(extracellular exosomes, intracellular organelles lumen, 
mitochondrion, nucleus). Moreover, the biological 
meaning and functional pathways were extracted by using 
DAVID Bioinformatics Resources [45], where a high 
number of proteins with specific biochemical functions 
were found. In particular, the majority of the identified 
proteins can be classified into 5 different groups namely: 
mitochondrial proteins, endoplasmic reticulum lumen 
Figure 5: Detection of Apoptosis and autophagy on SKBR3 cells treated with AgNPs-EPS. (A) Flow cytometry analysis of 
DNA distribution in propidium iodide-stained cells. (B) Genomic DNA separated on 1% agarose gels, and visualized by gel red staining. 
(C) Fluorescence micrographs after Acridine Orange, Monodancylcadaverine and Lysotracker staining for labeling of acidic vesicular 
organelles (AVO), autophagosomes/autolysosomes respectively. (D) Western blot analysis showing the effect of AgNPs-EPS treatment on 
the expression of autophagic protein markers. Actin was used as loading control.
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proteins, proteins involved in regulation of apoptosis, 
proteins involved in the response to oxidative stress 
and glycolytic proteins. Figure 8 reports the histograms 
of protein level variations following the AgNPs-EPSaer 
treatment, compared with the untreated cells. Interestingly, 
proteomics results highlights important pathways involved 
in the mechanism of action of AgNPs-EPSaer on SKBR3 
cells and strengthens our previous observations on its 
biological function. In particular the differentially proteins 
identified can efficiently explain the cellular effects of 
AgNPs-EPSaer. Infact accumulating evidence suggests that 
protein folding and generation of reactive oxygen species 
(ROS) as a byproduct of protein oxidation in the ER are 
closely linked events [46]. Persistent oxidative stress and 
protein misfolding initiate cell death cascades, involving 
mitochondrial disfunctions; moreover, mitochondrial 
turnover is dependent on autophagy. Collectively, the 
dow-regulation of glycolitic enzymes suggest a partial 
reversion of the so called Warburg effect, first described 
by Otto Warburg, and considered an important cancer 
hallmark [47]. 
Uptake of AgNPs-EPSaer by SKBR3 cells
TEM micrographs (Figure 9) showed that AgNPs-
EPSaer treated cells exhibited numerous endosomes with 
Figure 6: Differential proteomic analysis of SKBR3 cells treated with AgNPs-EPS. (A) Proteomic map of SKBR3 control 
cells. Labels indicate the 253 differential protein spots. (B) Eulero Venn diagram showing the differentially expressed proteins selected on 
the threshold setting in the studied groups; (C) Histograms showing the up and down-regulated proteins plotted as fold change compared 
to untreated cells.
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engulfed nanoparticles and autophagic vacuoles filled with 
structures resembling mitochondria. Moreover numerous 
exocytic vesicles and pseudopodia were also observed. 
Only few nanoparticles were observed within the nucleus, 
because the matrix is more electron dense than the 
cytoplasm and it is more difficult to distinguish the single 
silver nanoparticles.
Determination of total silver in cell fractions
Inductively coupled plasma atomic emission 
spectrometry (ICP), was used to measure the 
concentration of total silver in cell fractions (nuclei, 
mitochondria, lysosomes and membranes) obtained by 
sequential centrifugation of AgNPs treated cells for 24 
Figure 7: Protein-protein interaction networks. (A) Functional interaction network of AgNPs-EPSaer regulated proteins created 
by String algorithm. Stronger interactions are represented by thicker lines. (B) Miniatures of functional network sorted by enriched Gene 
Ontology terms: biological processes, molecular functions and cellular components. For each group the involved proteins are highlighted 
in red.
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Figure 8: Histograms of the differentially identified proteins in SKBR3 AgNPs-EPSaer treated cells, sorted into 
functional classes and plotted as fold change compared to untreated cells.
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h. As expected, higher Ag concentration was detected 
in AgNPs-EPSaer treated cells compared to AgNPs-
EPSanaer treated cells. Interestingly, tot-Ag was detected 
only in mitochondria and nuclei fractions, with a higher 
concentration in mitochondria with respect to nuclei 
(Figure 10), suggesting a prominent role of mitochondria 
in AgNPs-EPSaer-toxicity. Mitochondria, resembling to 
bacteria, likely have a similar mechanism of transportation 
for Ag+ in E.coli [24].
Excitation emission spectroscopy of DNA 
The interaction of Ag+ with DNA was studied with 
EEM spectroscopy. For this purpose the three dimensional 
excitation emission matrix (EEM) fluorescence 
spectroscopy was used to characterise and distinguish 
the DNA from the Ag-DNA. This fluorescence method 
is specific, sensitive and reliable enough to characterise 
and distinguish even similar synthetic organic dyes [48]. 
The fingerprints of EEM spectra of DNA extracted from 
cell line SKBR3 show significant changes in the Eex/Eem 
contour for exposed and unexposed cells. The intrinsic 
fluorescence of DNA from untreated cells which are 
excited with Eex = 270 nm produces two sharp Eem peaks: 
the first peak centred at 315 nm and the second peak 
centred at 604 nm (Figure 11). The same pattern was 
detected in exposed cells to IC50 of AgNPs-EPS
aer for 24 h 
(data not shown). Accordingly to ICP results, these results 
reinforce the idea that at 24h of treatment DNA is not 
the primary target of AgNPs-EPsaer treatment. The EEM 
contours have significantly changed when the cell remains 
exposed to AgNPs-EPsaer with an higher concentration (50 
mg/ml) or for a longer time (48 h). In these conditions 
the first peak doubled in two peaks namely (1a) and (1b), 
with an important shift of peak (1a) from 315 to 327 nm 
and with a new peak (1b) at 373 nm. The second DNA 
peak was shifted from 604 nm of the control cells to 619 
nm of silver exposed cells. The intensity (RFU) of peaks, 
the shifts, and in particular the doubling of first peak are 
to be considered as caused by DNA interaction with Ag+. 
These peaks are similar to those produced in vivo with 
E.coli [24] and in vitro by Ag+ complexed by synthetic 
DNA oligonucleotides [49, 50].These results could 
indicate that in the long-time treatment with AgNPs-EPsaer 
increase and/or stabilise the interaction of silver with DNA 
inducing cell death [51].
DISCUSSION
Metal nanoparticles are versatile agents with a variety 
of applications and in particular in nanomedicine for highly 
sensitive diagnostic assays, thermal ablation, radiotherapy 
enhancement including drug and gene delivery [14]. In 
this study, two biogenerated AgNPs-EPS has been used 
to induce toxicity and to study the mechanisms of toxicity 
in a breast cancer cell line SKBR3. Both AgNPs-EPS 
were already characterized and used for antimicrobial 
activities [24]. The most important characteristics of silver 
nanoparticles used in this study are: the spherical shape 
with an average size of 11 ± 5 nm. The concentration of 
total silver in AgNPs-EPSaer is 12.1 % while in AgNPs-
EPSanaer is 5.2 %, whereas the relative productions of 
AgNPs-EPSaer and AgNPs-EPSanaer were 170 and 312 mg/L, 
respectively. Information on reactivity of AgNPs and the 
release of Ag(I) species at the AgNPs-EPS/water interface 
was obtained by combining SECM and voltammetric 
experiments [25]. It is interesting to note that the amount of 
Ag(I) released from AgNPs-EPSaer is sensibly higher (4–6 
times) than that of AgNPs-EPSanaer. The composition of the 
AgNPs-EPS materials are differently rich of Ag(I)-NPs or 
Ag(0)-NPs. As expected, Ag(I) forms predominate in the 
AgNPs-EPSaer material, conceivable due to the presence of 
oxygen, which could promote the oxidation of Ag(0)NPs to 
provide easier diffusible Ag(I) species. Accordingly to their 
chemical and physical properties, AgNPs-EPSaer showed 
most important biological activity in term of cytotoxic, 
morphologic and proteomic effects. We also verified a 
selective action of AgNPs-EPSaer in SKBR3 breast cancer 
cells compared to the non tumoral mammary cell line 
HB2. Since cancer cells display an altered metabolism 
Figure 9: TEM micrographs of SKBR3 cells treated with AgNPs-EPSaer. Arrow indicates endosomes while asterisk indicates 
vesicles and pseudopodia.
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and increased glucose uptake, irrespective of oxygen 
availability (aerobic glycolysis or Warburg effect) [52], we 
believe that they are able to detect the sugars present in 
the EPS and to pick it with greater efficiency compared to 
normal cells. Recently, carbohydrates have been considered 
as biomimetic functional molecules on the surface of 
nanoparticles [53] also because they trigger cellular uptake 
via specific receptors or endocytosis. TEM analysis showed 
that AgNPs-EPSaer uptake occurs through endocytosis and, 
as suggested by colony formation assay, the effects are 
evident after 1h of treatment. Moreover, AgNPs-EPSaer 
treatment inhibited migration and invasion capability of 
tumoral cells, considered as a cancer hallmark, suggesting 
a potential anticancer effect.
Findings from several studies reported that both 
the AgNPs and Ag+ released by AgNPs are involved in 
the mechanism of cytotoxicity in different ways: infact, 
AgNPs probably provide a perfect surface outside the 
mitochondria for the univalent reduction of oxygen to 
superoxide from electron through the electron transport 
chain. On the other hand, Ag+ binds to proteins and DNA, 
interfering with their functions [54]. Moreover, ROS 
generation and oxidative stress occur as an early event 
leading to NP-induced toxicity [38].
Our results point in the same direction suggesting 
that the cellular response to AgNPs-EPSaer exposure is the 
sum of events triggered by a direct effect of the cellular 
uptake of AgNPs, as verified by TEM analysis, induction 
of intracellular ROS and an indirect effect of free Ag+ 
ions released mainly in mitochondria and secondarily in 
the nuclei, where they interact with DNA. To the best 
of our knowledge this is the first study reporting quali-
quantitative evidences about the effects of siver ions 
released by nanoparticles in different cell compartments.
It is generally accepted that ROS induce autophagy 
and/or apoptosis. Moreover, it has been documented that 
autophagy may act as enabler of apoptosis, contributing 
in certain morphological and cellular events that 
take place in apoptotic cell death [55]. Autophagic 
cell death has morphologic and biochemical features 
distinguishing it from both apoptosis and necrosis. 
Autophagy consists of several sequential steps starting 
with the autophagosome formation and then progresses 
to autophagolysosomes through the fusion of acidic 
lysosomes with autophagosomes [56–58]. Several 
proteins can be used as markers to study autophagic 
flux: in particular, during autophagy, ATG proteins 
(eg ATG5 and ATG7) and Beclin -1, have an essential 
role in the autophagosome formation [59]. Later, 
autophagosomes (LC3-containing vacuoles) fuse with 
lysosomes to cause the degradation of their contents. 
The protein p62/SQSTM1 binds directly to LC3 and 
is itself degraded [60, 61]. Moreover, inhibition of 
HSP90 plays an important role in autophagy inducing 
degradation of Hsp90 client proteins, such as AKT 
[62, 63]. PI3K/AKT/mTOR axis downregulation lead 
to the activation of autophagy and the inhibition of 
cell proliferation, also [63]. We found that SKBR3 
treated with AgNPs-EPSaer underwent morphologic and 
biochemical changes consistent with the induction of 
autophagy and secondarily of apoptosis, as suggested by 
the upregulation of lysosomes, autophagolysosomes and 
Figure 10: Determination of total silver by ICP in cell fractions. Data were normalized for protein concentration. ND means not 
detected.
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acidic vescicular organelles, the down regulation of AKT, 
p-AKT, HSP90 and p62 the increment of ATG5, ATG7 
and beclin-1 and the conversion of LC3-I to LC3-II. 
Concerning the apoptosis, only the 11% of treated cells 
underwent to apoptotic cell death and accordingly, no 
DNA fragmentation was evident in our analysis at 24h, 
although the increment of Ag+-DNA binding was evident 
after 48h of treatment. 
Several evidences suggested that activation of 
autophagy, is also dependent by the accumulation 
of oxidatively damaged proteins and subsequent 
endoplasmic reticulum stress, or mitochondrial damage 
[34, 64–66]. Our proteomic results are in agreement with 
these observations. The differentially proteins identified 
so far, highlights important pathways involved in the 
mechanism of action of AgNPs-EPSaer. The endoplasmic 
reticulum (ER) is a well-orchestrated protein-folding 
machine composed of protein chaperones, proteins that 
catalyze protein folding, and sensors that detect the 
presence of misfolded or unfolded proteins. The protein 
folding and generation of reactive oxygen species (ROS) 
as a byproduct of protein oxidation in the ER are closely 
linked events, and persistent oxidative stress and protein 
misfolding initiate cell death. Autophagy is emerging 
as an important mediator of pathological responses 
and engages in cross-talk with ROS. Oxidative stress 
is inseparably linked to mitochondrial dysfunction, 
as mitochondria are both generators of and targets for 
reactive species. Moreover, the mitochondrial turnover 
is dependent on autophagy. We believe that proteomic 
pathways disclosed in this study represent an important 
advance about the mechanisms of AgNPs-EPSaer induced 
toxicity according to a modern omic-research direction 
in cancer therapy. 
Figure 11: Excitation-emission spectroscopy of DNA. Determination of intrinsic DNA fluorescence. The DNA was extracted from 
SKBR3 treated and untreated with AgNPs-EPsaer. The Eex was set at 270 nm and the Eem were ranging from 200 to 700 nm. The relative 
fluorescence units (RFU) of intensities and the 3 emission peaks (1a, 1b and 2) were reported. R1 and R2 corresponded to the Rayleigh 
scattering peaks.
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In conclusion, our results suggest a so-called 
“Trojan-horse” mechanism [67], in which AgNPs-EPSaer 
internalized within the cells access the mitochondria and 
nuclei where release Ag ions, which determine oxidative 
stress and cell death. The crosstalk between autophagy, 
redox signaling and mitochondrial dysfunction is not 
well understood and further efforts are necessary to 
analyze the oxidative stress-ER stress-mitochondria 
connectivity and apoptosis/autophagy. These interesting 
results encourage further studies to highlight the in vivo 
effects on breast cancer cells.
MATERIALS AND METHODS
Culture conditions production of two AgNPs-
EPS
Cells of K. oxytoca DSM 29614 strain were stored in 
cryovials at –80°C in 25% glycerol solution until they were 
revitalized in Nutrient Broth (Difco), When the strain was 
grown under anaerobic and aerobic conditions the NAC 
medium, buffered at pH 7.8, was used (2.5 g/L NaHCO3, 
1.5 g/L ammonium acetate, 1.5 g/L MgSO4.7H2O, 0.6 g/L 
NaH2PO4, 0.1 g/L potassium acetate, and 14.7 g.l
-1 sodium 
citrate) [22]. The anaerobic medium was cooled under N2 
flux and then was sealed. An overnight pre inoculum of 
cells was prepared and inoculated both into this oxygen-
free medium and that aerated medium with 10 ml of DSM 
29614 culture (OD600nm = 1.0) and incubated at 30°C. After 
3 days incubation for aerobic medium and after 6 days 
for anaerobic medium, 50 mg of Ag+, such as AgNO3, 
was added in both cultures. The growth of the strain 
was followed by determining total proteins according 
to Bradford micro-method recommended by Bio-Rad 
reagent. After 2 days from Ag+ additions both precipitates 
were recovered by a gently centrifugation (1000 g x 20 
min). The precipitated cells were removed by further 
centrifugations. The polysaccharide fraction was washed 
twice with milliQ water and the polysaccharide was 
precipitated with 70% ethanol solution overnight at 4°C. 
Both ethanol precipitates were dried out under vacuum 
and grinded in a mortar. Thereafter the two biogenerated 
silver nanoparticles were designed as AgNPs-EPSaer and 
of AgNPs-EPSanaer.
Cell culture and treatments
SKBR3, 8701-BC, HT29 and HCT116, were 
cultured in RPMI 1640 media (Gibco, Paisley, UK), 
while CaCo2 cells were cultured in DMEM medium, 
supplemented with 10% heat-inactivated fetal bovine 
serum and 100U/mL penicillin and 100 µg/mL 
streptomycin, as already described [33, 68–71]. The 
human mammary epithelial cell line HB2, already 
characterized for proteomic profile [70], was grown 
in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10 % fetal bovine serum, 100 U/mL 
penicillin and 100 µg/mL streptomycin, hydrocortisone 
(5 μg/mL) and insulin (10 μg/mL). All culture cells were 
maintained at 37°C and 5% CO2. Cells were seeded at 
cell density of 2 × 104/cm2, and to 70% confluence they 
were treated with different concentrations of AgNPs-
EPSanaer, AgNPs-EPSaer and metal-free EPS (produced 
in absence of metal), for 24 h for all experiments. 
Where not expressed, the cells were treated with the 
corresponding IC50 values. 
Cell viability assay 
The cytotoxic activity of both NPs-EPS was 
determined using MTT assay (Promega, Madison, WI, 
USA), as previously described [69, 72]. Briefly, cells 
were plated at 5 × 103 cells/well in 96-well plates. NPs-
EPS, diluted to the desiderated concentrations in culture 
medium, were added to the wells with respective vehicle 
control (H2O). Doxorubicin hydrochloride (Sigma, st. 
Louis, MO) was used as reference drug. After 24 h of 
incubation 20 µL of the Cell titer 96®AQueous reagent was 
added to each well after three washes with phosphate 
buffer saline (PBS) and incubated for 1-4 h at 37 °C in 
a CO2 incubator. The absorbance was recorded at 490 
nm using a 96-well plate reader (Spark® 20M, Tecan 
Trading AG, Switzerland). The percentage of cell viability 
was calculated with respect to untreated control cells 
for each treatment after subtraction of the blank. The 
concentration necessary for 50% of growth inhibition 
(IC50) was calculated using a dose–response model, which 
was obtained from sigmoidal fitting of response curves 
of percent inhibition versus logarithmic concentration of 
DOSs using Graph Pad Prism software. Each result was 
the mean value of three different experiments performed 
in triplicate.
Colony formation assay
This assay identifies the cell populations that survive 
following a cytotoxic treatment. Cells were seeded at a 
density of 200, 400 and 800 cells in 6-well plates. After 2 
h, the cells were treated for 1 h and for 24 h with 5 and 50 
μg/L of AgNPs-EPS. At the end of the incubation period, 
medium was replaced with fresh medium and cells were 
incubated for 10 days. Colonies were fixed and stained 
with a mixture of 6.0% glutaraldehyde and 0.5% crystal 
violet and then counted microscopically using 10× high 
power fields. Clonogenic index was then calculated as the 
ratio of plating efficiency of treated cells on wells divided 
by the number of cells in the control wells.
Cell migration
Cell migration was studied by using an in vitro 
scratch assay. SKBR3 cells were seeded on 24-well tissue 
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culture plates and grown to 100% confluence. Wounds 
were created by scraping the monolayer of cells with a 
sterile pipette tip, washed with PBS to remove the floating 
cells and incubated with fresh medium in the presence 
or absence of AgNPs-EPS. The images of scratched area 
were captured (at 40× magnification) using an inverted 
microscope equipped with digital camera immediately 
after wounding and after 6 and 24 h. The scratched area 
was calculated by Image J software.
Gelatin zymography
SKBR3 cells (5 × 104 cells/well) were seeded on 
6-well plates, grown to 90% of confluence and treated 
for 24h with AgNPs-EPS IC50 in a serum-free medium. 
Conditioned media were collected, centrifuged to remove 
cellular debris, dialyzed and lyophilized. Equal amounts of 
total proteins (5 µg) were separated by electrophoresis, on 
a 7.5% sodium dodecyl sulfate (SDS)–polyacrylamide gel 
containing 0.1% gelatin, under non-reducing conditions. 
After electrophoresis, the gels were washed for 1h with 
a buffer containing 50 mM Tris-HCl, pH 7.5 and 2.5% 
Triton X-100, to remove the SDS and then incubated with 
activation buffer containing 50 mM Tris-HCl, pH 7.5, 150 
mM NaCl, 5 mM CaCl2, for 18h at 37 °C. Gel was stained 
with Coomassie Brilliant Blue G 250 and de-stained with 
H2O milliQ. The bands intensity were measured with 
Image J software.
Morphological assessment and Acridine orange/
Ethidium bromide (AO/EB) 
SKBR3 cells were seeded in 12 well culture plates 
with a cell density of 1 × 105 cells/well. After 24 h cells 
were incubated for 24 h with the IC50 concentration of the 
AgNPs-EPSaer, and observed for morphological changes 
assessment under a phase contrast inverted microscope 
(Carl Zeiss) at 400X magnification. For AO/EB, the cells 
were seeded at the same conditions in a cover slip and after 
treatments, cells were washed twice with PBS and stained 
for few minutes with 200 μL of the Acridine Orange 
(100μg/mL), Ethidium Bromide (100μg/mL) mixture (1:1, 
v/v). Cells were immediately observed under a fluorescent 
microscopy (Carl Zeiss) at 630X magnification.
Evaluation of ROS generation
Intracellular ROS levels were measured by using 
2′,7′-dichlorodihydrofluorescein diacetate (DCFH-
DA) and Dihydroethidium (DHE) assays. DCFH-DA 
is routinely used to measure intracellular generation 
of H2O2 and other oxidants; it is a cell-permeable 
probe, hydrolyzed intracellularly to the DCFH. Two-
electron oxidation of DCFH results in the formation of 
a fluorescent product, dichlorofluorescein (DCF). DHE 
is another widely used probe for detecting intracellular 
O2
-.The red fluorescence formed from the two-electron 
oxidation product, is usually equated to intracellular 
superoxide formation. SKBR3 cells were plated in 96 
well plates at a density of 5 × 103/well, allowed to growth 
overnight and incubated for 24 h with different AgNPs-
EPSs concentrations. At the end the medium was replaced 
with the culture medium containing DCFH-DA (10 μM) 
and DHE (10 μM) and incubated for 30 min at 37°C. Then 
the medium was replaced with PBS and the fluorescence 
intensity was analyzed by spectrofluorimeter with an 
excitation of 488 nm and emission wavelength of 525 nm 
for DCFH-DA and an excitation of 540 nm and emission 
wavelength of 590 nm for DHE. Data normalization was 
performed with parallel MTT assay. 
DNA extraction and flow cytomety 
DNA was extracted from SKBR3 treated cells as 
previously described [73], with some modifications. 
The cells were detached from the flasks with trypsin and 
suspended in 0.5 ml of TE buffer (100 mM Tris-HCl, 
100 mM EDTA pH 8). 50 µl of 10% SDS and 25 µl of 
1 mg/ml Proteinase K were added to the cell suspension 
and incubated for 30 minutes at 55°C. Nucleic acids 
were extracted using phenol-chloroform, precipitated 
with 1/10V 3M Na-acetate and 2V absolute ethanol and 
resuspended in 100 µl TE buffer. The same quantity of 
extracted DNA was loaded on a 1% agarose gel prepared 
in 0.5X TE buffer containing gel red. Gel was visualized 
under UV light using a Bio-Rad Trans illuminator and 
photographed by using a Polaroid camera. 
Apoptosis of SKBR3 cells after treatment with IC50 
of AgNPs-EPS for 24 h was analyzed by flow cytometry 
essentially as described by Riccardi [74]. Briefly cells were 
fixed in 70% ethanol, washed in PBS and resuspended in 
DNA extraction buffer (200 mM Na2HPO4, 0.1% Triton 
X-100). After staining with Propidium Iodide (1µg/mL) 
for 30 min, fluorescence intensity was acquired in the 
FL2 channel by flow cytometry on a FACSCalibur flow 
cytometer (BD, New Jersey, USA). Data acquisition 
was performed with CellQuest Pro (BD) software, and 
analyzed with WinList software (Verity Software House, 
Topsham, USA).
Fluorescence staining with Acridine Orange 
(AO), monodansylcadaverine (MDC) and 
Lysotracker®
SKBR3 cells were grown on coverslips and 
treated for 24 h with the IC50 concentration of AgNPs-
EPSaer. Acidic vesicular organelles (AVOs) were labeled 
with 1 µg/ml of Acridine Orange, autophagosomes and 
autolysosomes with 0.05 mM of MDC (Sigma, St. Louis, 
MO, USA) while acidic compartments were labeled 
by incubating the cells with 75 nM of LysoTracker® 
(Molecular Probes, Life Technologies) in the culture 
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media for 1min at RT. After incubation, cells were washed 
several times with PBS and immediately analyzed by 
fluorescence microscopy using the appropriate filter 
system.
Western blotting analysis
SKBR3 cells were treated for 24h with IC50 
concentrations of AgNPs-EPS and with 200 µg/ml of free-
metal EPS. After washing with PBS, cells were carefully 
scraped and incubated on ice for 30 min Lysis buffer 
containing 7 M urea, 2 mM Thiourea, 0.4 % w/v CHAPS, 
1 % w/v 1,4-dithioerythritol (DTE) and 30mM TRIZMA 
base, pH 8.5. The total cellular lysate was centrifuged at 
14,000 rpm for 10 min to clear cell debris and protein 
concentration determined by Bradford assay, as already 
reported [75, 76]. Protein samples (20 μg/lane) were 
subjected to SDS polyacrylamide gel electrophoresis, then 
transferred to a nitrocellulose membrane (HyBond ECL, 
Amersham) and stained with Ponceau S (Sigma Aldrich). 
Western blotting analyses were performed using a rabbit 
polyclonal antibodies for Akt 1-2-3 and pAkt 1-2-3, a goat 
polyclonal antibody for Beclin 1, a mouse monoclonal 
antibody for Actin β, HSP90, MMP2 and MMP9 by 
Santa Cruz Biotechnology (Santa Cruz, CA, USA), a 
rabbit polyclonal antibody for LC3 by Sigma Aldrich and 
a rabbit polyclonal antibodies for p62, ATG5 and ATG7 
by Cell Signaling Technology. Following incubation with 
the appropriate peroxidase-linked antibody, the reaction 
was revealed by the ECL detection system, using high 
performance films (Hyperfilm ECL, Amersham), as 
already described [68, 77]. The correct protein loading was 
ascertained by red Ponceau staining and immunoblotting 
for Actin β. 
Subcellular separation for Ag+ release 
After treatments, SKBR3 cells were detached from 
the flasks with a scaper and resuspended in Sucrose buffer 
(5mM Tris-HCl pH 7.4, 0.32M Sucrose and 0.001 mg/
mL Protease/phosphatase inhibitor). Nuclei were pelleted 
by centrifugation at 1000 g for 20 minutes; mitochondria 
from the post-nuclear supernatants were recovered by 
centrifugation at 8500 g for 30 minutes; lysosome by 
centrifugation at 20000 g for 30 minutes and membranes 
by centrifugation at 105000 g for 90 minutes. The Ag+ 
release from subcellular components was measured by 
scanning electrochemical microscopy and anodic stripping 
voltammetry (ASV) using a CHI920B workstation (CH 
Instruments), as already described [24, 25]. 
Determination of total Ag 
Total silver was determined in 1 mg sample 
of pulverized AgNPs-EPSaer, AgNPs-EPSanaer and in 
subcellular fractions of breast cancer cell line SKBR3. 
Samples were digested with 2 mL of aqua regia, heating 
at 60° until a solution was obtained. Total Ag was 
determined by Inductively Coupled Plasma Atomic 
Emission Spectrometry, ICP-AES (Optima 3100, Perkin 
Elmer) [78].
2D-DIGE analysis 
Protein samples were labeled for 2D-DIGE 
analysis using CyDyeTM DIGE minimal labeling kit 
(GE Healthcare, Sweden), according to manufacturer’s 
recommendations as already described [18]. An 
internal standard was generated by combining equal 
amounts of samples and labeled with Cy2 Protein 
samples (50 μg) were labeled with 200 pmol of CyDye 
on ice in the dark for 30 min. Labeling reaction was 
quenced by addition of 1 μl of 10 mM lysine, and 
incubation was continued on ice for 10 min, in the 
dark. The first dimensional separation was performed 
at 20°C on commercial sigmoidal immobilized pH 
gradient strips (IPG), 18 cm long with pH range 3.5 
to 10 (Pharmacia). Strips were rehydrated in 8 M 
urea, 2% CHAPS, 10 mM DTE, and 0.5% carrier 
ampholytes (Resolyte 3.5–10). The isoelectrofocusing 
was carried out by linearly increasing voltage from 
200 to 3500 V during the first 3 hr, after which 
focusing was continued at 8000 V for 8 hr, as already 
described [33, 68–72, 75–77, 79–84]. After the first 
dimension separation the IPG strips were equilibrated 
with a solution containing 6 M urea, 30% glycerol, 2% 
SDS, 0.05M Tris-HCl pH 6.8, and 2% DTE for 12 min, 
to resolubilize proteins and reduce disulphuric bonds. 
The -SH groups were then blocked by substituting the 
DTE with 2.5% iodoacetamide in the equilibrating 
buffer. The focused proteins were then separated on 
9–16% linear gradient polyacrylamide gels (SDS-
PAGE) using a DALT six (GE Healthcare) apparatus 
with a constant current of 40 mA/gel at 10°C. Images 
were acquired with a Typhoon FLA 9500 scanner 
(GE Healthcare), using specific emission filters, and 
analyzed by the Image Master 2D Platinum 7 software 
(GE Healthcare). Protein spots showing more than 
1.3 fold change in spot volume (increased for up-
regulation or decreased for down-regulation), with 
a statistically significant ANOVA value (p ≤ 0.05), 
were considered differentially represented and further 
identified by MS analysis. After the acquisition, each 
gels were stained with ammoniacal silver nitrate, as 
already described [80]. 
In-gel digestion and MS analysis of tryptic 
digests
Spots of interest were manually picked and mass 
spectrometric sequencing was carried out after in-gel 
digestion, using sequencing-grade trypsin (20 μg/vial), 
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according to the method of Shevchenko et al. with some 
modifications as already described [85]. The tryptic peptide 
extracts were dried in a vacuum centrifuge and dissolved 
in 0.1% trifluoroacetic acid (TFA). Peptide mixtures were 
desalted by μZip-TipC18 (Millipore, MA)). The matrix, 
R-cyano-4-hydroxycinnamic acid (HCCA), was purchased 
from Sigma-Aldrich. A saturated solution of HCCA (1 μL) at 
2 mg/200 μL in CH3CN/H2O (50:50 (v/v)) containing 0.1% 
TFA was mixed with 1 μL of peptide solution and loaded onto 
the MALDI target plate and left to dry. A peptide calibration 
standard was spotted separately onto the MALDI target plate. 
Mass spectra were obtained using an Ultraflex MALDI-
TOF-TOF (Bruker Daltonics, Bremen, Germany) or a 
MALDI-TOF Voyager DE-PRO (Applied Biosystems) mass 
spectrometer. Peptide mass fingerprinting was compared to 
the theoretical masses from the Swiss-Prot or NCBI sequence 
databases using Mascot (http://www.matrixscience.com/). 
Typical search parameters were as follows: 50 ppm of mass 
tolerance, carbamidomethylation of cysteine residues, one 
missed enzymatic cleavage for trypsin, a minimum of four 
peptide mass hits was required for a match, methionine 
residues could be considered in oxidized form, no restriction 
was placed on the isoelectric point of the protein, and a 
protein mass range from 5 to 100 kDa was allowed. 
Transmission electron microscopy (TEM) 
analysis
Cells were grown to confluence in a 12-well plate 
and treated with appropriate concentrations of both 
AgNPs-EPS for 24 h, washed in 0.075 M phosphate 
buffer pH 6.9 and immediately fixed in a solution of 3% 
glutaraldehyde in cacodylate buffer 0,066M pH 7.2 for 
30 min as already described [72]. Then the cells were 
dehydrated using increasing concentrations of ethanol (10, 
30, 50, 70 and 100%) at room temperature and gradually 
infiltrated in Spurr’s low viscosity embedding resin 
and polymerized at 70°C for 8 h. After polymerization, 
specimens were sectioned with an ultramicrotome (model 
LKB III) using a diamond knife. The thin sections were 
collected on copper grids, stained for 10 min in 2% uranyl 
acetate and 5 min in lead citrate and then they were 
observed  by Transmission Electron Microscopy (PHILIPS 
268 Morgagni, FEI ) operating under standard conditions.
Fluorescence spectra of DNA
The emission-excitation (EEM) spectra of DNA 
were recorded by Luminescent Spectrometer (Perkin 
Elmer LS 55). The instrument was equipped with a Xenon 
discharge lamp equivalent to 20KW for 8 µs duration 
pulse, wide at half eight minor 10µs with excitation slit 
5 nm and emission slit 5 nm. The extracted DNA was 
suspended in 1 ml milliQ and transferred in cuvette for 
fluorescence analyses. The EEM scan spectra were 
measured by scanning simultaneously both the excitation 
(Eex), which ranged from 200 to 320 nm, and the emission 
(Eem), which ranged from 200–700 nm. The EEM contour 
maps were obtained by original equipped computer 
software. The relative fluorescence units (RFU) of peaks 
were also determined.
Statistical analysis
Results are presented as means ± standard error. Data 
were analysed using Student’s t-test. p < 0.05 was considered 
significant; p < 0.01 was considered highly significant and p 
< 0.001 was considered very highly significant.
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